Saba Capital Management, L.P. filed a Form 4 on November 6, 2026, disclosing a purchase of common stock in Gabelli Healthcare & WellnessRx Trust on November 5, 2026.

Key Highlights

  • Transaction: Saba Capital Management, L.P. acquired 8,916 shares of common stock on November 5, 2026.
  • Price paid: Shares were purchased at $10.44 each, according to the filing.
  • Post-transaction holdings: Saba Capital reported beneficial ownership of 2,195,738 shares following the transaction.
  • Ownership status: The filing identifies Saba Capital Management, L.P. as a 10% owner of the issuer.
  • Indirect ownership: The shares are held indirectly, through funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager.
  • Key principal: Boaz R. Weinstein serves as the managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P.

Saba Capital Management Adds to GRX Position in November 2026

According to the Form 4 filed with the U.S. Securities and Exchange Commission on November 6, 2026, Saba Capital Management, L.P. purchased 8,916 shares of common stock in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) on November 5, 2026, at a price of $10.44 per share. The transaction is coded "P," indicating an open-market purchase.

The filing reports that following this acquisition, Saba Capital Management holds beneficial ownership of 2,195,738 shares on an indirect basis. The filing notes that "the securities reported herein are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager." Boaz R. Weinstein is identified as the managing member of Saba Capital Management GP, LLC, which is the general partner of Saba Capital Management, L.P. The form was signed by Maria Piccolino on behalf of Saba Capital Management, L.P., and also bears the name of Boaz Weinstein, both dated November 6, 2026.

Saba Capital Management, L.P. is listed in the filing as a 10% owner of the issuer. No derivative securities transactions were reported. The form covers only the single common stock purchase described above, and no amendment date is listed, indicating this is an original filing.

What Was Disclosed

Saba Capital Management, L.P. disclosed the purchase of 8,916 shares of Gabelli Healthcare & WellnessRx Trust common stock at $10.44 per share on November 5, 2026, bringing its indirectly held beneficial ownership to 2,195,738 shares.